Literature DB >> 26008169

New challenges in the diagnosis and management of cystic fibrosis.

Hara Levy1, Philip M Farrell2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26008169      PMCID： PMC4477509          DOI： 10.1016/j.jpeds.2015.03.042

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  28 in total

1.  Sweat testing infants detected by cystic fibrosis newborn screening.

Authors:  Richard B Parad; Anne Marie Comeau; Henry L Dorkin; Mark Dovey; Robert Gerstle; Thomas Martin; Brian P O'Sullivan
Journal:  J Pediatr       Date:  2005-09       Impact factor: 4.406

Review 2.  The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.

Authors:  B J Rosenstein; G R Cutting
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

3.  Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!

Authors:  Philip M Farrell; HuiChuan J Lai; Zhanhai Li; Michael R Kosorok; Anita Laxova; Christopher G Green; Jannette Collins; Gary Hoffman; Ronald Laessig; Michael J Rock; Mark L Splaingard
Journal:  J Pediatr       Date:  2005-09       Impact factor: 4.406

4.  Recommendations for the classification of diseases as CFTR-related disorders.

Authors:  C Bombieri; M Claustres; K De Boeck; N Derichs; J Dodge; E Girodon; I Sermet; M Schwarz; M Tzetis; M Wilschanski; C Bareil; D Bilton; C Castellani; H Cuppens; G R Cutting; P Drevínek; P Farrell; J S Elborn; K Jarvi; B Kerem; E Kerem; M Knowles; M Macek; A Munck; D Radojkovic; M Seia; D N Sheppard; K W Southern; M Stuhrmann; E Tullis; J Zielenski; P F Pignatti; C Ferec
Journal:  J Cyst Fibros       Date:  2011-06       Impact factor: 5.482

5.  Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening.

Authors:  Clement L Ren; Aliza K Fink; Kristofer Petren; Drucy S Borowitz; Susanna A McColley; Don B Sanders; Margaret Rosenfeld; Bruce C Marshall
Journal:  Pediatrics       Date:  2015-05-11       Impact factor: 7.124

6.  The need for quality improvement in sweat testing infants after newborn screening for cystic fibrosis.

Authors:  Vicky A Legrys; Susanna A McColley; Zhanhai Li; Philip M Farrell
Journal:  J Pediatr       Date:  2010-09-16       Impact factor: 4.406

7.  Novel CFTR variants identified during the first 3 years of cystic fibrosis newborn screening in California.

Authors:  Lisa Prach; Ruth Koepke; Martin Kharrazi; Steven Keiles; Danieli B Salinas; Maria Carmen Reyes; Mark Pian; Harry Opsimos; Kimberly N Otsuka; Karen Ann Hardy; Carlos E Milla; Jacquelyn M Zirbes; Bradley Chipps; Susan O'Bra; Muhammad M Saeed; Reddivalam Sudhakar; Susan Lehto; Dennis Nielson; Gregory F Shay; Mary Seastrand; Sanjay Jhawar; Bruce Nickerson; Christopher Landon; Ann Thompson; Eliezer Nussbaum; Terry Chin; Henry Wojtczak
Journal:  J Mol Diagn       Date:  2013-06-28       Impact factor: 5.568

8.  Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.

Authors:  Drucy Borowitz; Karen A Robinson; Margaret Rosenfeld; Stephanie D Davis; Kathryn A Sabadosa; Stephanie L Spear; Suzanne H Michel; Richard B Parad; Terry B White; Philip M Farrell; Bruce C Marshall; Frank J Accurso
Journal:  J Pediatr       Date:  2009-12       Impact factor: 4.406

9.  Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study.

Authors:  Mei W Baker; Anne E Atkins; Suzanne K Cordovado; Miyono Hendrix; Marie C Earley; Philip M Farrell
Journal:  Genet Med       Date:  2015-02-12       Impact factor: 8.822

10.  Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2.

Authors:  Fred A Wright; Lisa J Strug; Vishal K Doshi; Clayton W Commander; Scott M Blackman; Lei Sun; Yves Berthiaume; David Cutler; Andreea Cojocaru; J Michael Collaco; Mary Corey; Ruslan Dorfman; Katrina Goddard; Deanna Green; Jack W Kent; Ethan M Lange; Seunggeun Lee; Weili Li; Jingchun Luo; Gregory M Mayhew; Kathleen M Naughton; Rhonda G Pace; Peter Paré; Johanna M Rommens; Andrew Sandford; Jaclyn R Stonebraker; Wei Sun; Chelsea Taylor; Lori L Vanscoy; Fei Zou; John Blangero; Julian Zielenski; Wanda K O'Neal; Mitchell L Drumm; Peter R Durie; Michael R Knowles; Garry R Cutting
Journal:  Nat Genet       Date:  2011-05-22       Impact factor: 38.330
View more
  7 in total

Review 1.  Background and Epidemiology.

Authors:  Don B Sanders; Aliza K Fink
Journal:  Pediatr Clin North Am       Date:  2016-08       Impact factor: 3.278

2.  Refining the continuum of CFTR-associated disorders in the era of newborn screening.

Authors:  H Levy; M Nugent; K Schneck; D Stachiw-Hietpas; A Laxova; O Lakser; M Rock; M K Dahmer; J Biller; S Z Nasr; M Baker; S A McColley; P Simpson; P M Farrell
Journal:  Clin Genet       Date:  2016-01-20       Impact factor: 4.438

3.  Increased Expression of Plasma-Induced ABCC1 mRNA in Cystic Fibrosis.

Authors:  Justin E Ideozu; Xi Zhang; Amy Pan; Zainub Ashrafi; Katherine J Woods; Martin J Hessner; Pippa Simpson; Hara Levy
Journal:  Int J Mol Sci       Date:  2017-08-11       Impact factor: 5.923

4.  Sweat test and cystic fibrosis: overview of test performance at public and private centers in the state of São Paulo, Brazil.

Authors:  Maria Fátima Servidoni; Carla Cristina Souza Gomez; Fernando Augusto Lima Marson; Adyléia Aparecida Dalbo Contrera Toro; Maria Ângela Gonçalves de Oliveira Ribeiro; José Dirceu Ribeiro; Antônio Fernando Ribeiro
Journal:  J Bras Pneumol       Date:  2017 Mar-Apr       Impact factor: 2.624

5.  Quality of sweat test (ST) based on the proportion of sweat sodium (Na) and sweat chloride (Cl) as diagnostic parameter of cystic fibrosis: are we on the right way?

Authors:  Alethéa Guimarães Faria; Fernando Augusto Lima Marson; Carla Cristina de Souza Gomez; Maria Ângela Gonçalves de Oliveira Ribeiro; Lucas Brioschi Morais; Maria de Fátima Servidoni; Carmen Sílvia Bertuzzo; Eulália Sakano; Maura Goto; Ilma Aparecida Paschoal; Mônica Corso Pereira; Gabriel Hessel; Carlos Emílio Levy; Adyléia Aparecida Dalbo Contrera Toro; Andressa Oliveira Peixoto; Maria Cristina Ribeiro Simões; Elizete Aparecida Lomazi; Roberto José Negrão Nogueira; Antônio Fernando Ribeiro; José Dirceu Ribeiro
Journal:  Diagn Pathol       Date:  2016-10-26       Impact factor: 2.644

Review 6.  It All Depends What You Count-The Importance of Definitions in Evaluation of CF Screening Performance.

Authors:  Natasha Heather; Dianne Webster
Journal:  Int J Neonatal Screen       Date:  2020-06-10

7.  Sweat Proteomics in Cystic Fibrosis: Discovering Companion Biomarkers for Precision Medicine and Therapeutic Development.

Authors:  Bastien Burat; Audrey Reynaerts; Dominique Baiwir; Maximilien Fléron; Sophie Gohy; Gauthier Eppe; Teresinha Leal; Gabriel Mazzucchelli
Journal:  Cells       Date:  2022-07-31       Impact factor: 7.666
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.